Celltrion, Foreigners Net Sell 33,000 Shares... Stock Price -3.34%
As of 11:34 AM on the 4th, Celltrion is trading at 347,000 KRW, down 3.34% from the previous day. This represents a 14.0% decline compared to December 7. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners are tentatively recorded as net sellers of 33,000 shares of Celltrion, and institutions are net sellers of 32,000 shares. Over the past five days, individual investors have net sold 310,135 shares, while foreigners and institutions have net bought 332,749 shares and net sold 5,955 shares, respectively.
On December 29, Celltrion was in the spotlight in the market for completing the global Phase 2 clinical trial of the COVID-19 antibody treatment CT-P59.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If a Samsung Electronics Employee with a 100 Million Won Salary Receives a 600 Million Won Performance Bonus, Taxes Total 247.19 Million Won
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- "White House Blocks Repatriation of 'Ebola-Infected' Doctor... Ultimately Transferred to Germany"
- "4.15 Million Won Prada Jacket Shows White Spots After One Wear"...Korea Consumer Agency Orders Full Refund
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
